Kaspien Holdings Inc.: Nasdaq/NYSE listing notice — Kaspien receives Nasdaq notice for non-compliance with minimum bid price rule

Kaspien Holdings Inc.

Bid price below $1.00 for 30 consecutive business days triggered deficiency notice on Dec 14, 2022.
Company has 180 days, until June 12, 2023, to regain compliance by closing at $1.00 for 10 consecutive days.
If not compliant by June 2023, Kaspien may be eligible for additional 180-day cure period; otherwise delisting.
No immediate impact on listing; stock continues trading on Nasdaq; management evaluating options.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Kaspien Holdings Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

December 14, 2022, Kaspien Holdings Inc. (the “Company”) received written notice (the “Notice”) from The Nasdaq Stock Market (“Nasdaq”) that the closing bid price for its common stock had been below $1.00 for the previous 30 consecutive business days, and that the Company therefore is not in compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided a period of 180 calendar days, or until June 12, 2023, to regain compliance. In o

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001140361-22-045606

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.